Search the Newsroom
Filter By
News Type
Related specialties and programs
Showing 1 - 1 of 1 results
First Patients at CHOP Begin Newly Approved Sickle Cell Gene Therapies
CHOP announced that its first patients outside of clinical trials have begun the treatment process for the newly FDA approved sickle cell gene therapies.